Stay updated on Maintenance Therapy Trial: Odetiglucan & CD40 Agonist
Sign up to get notified when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.

Latest updates to the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page
- Check7 days agoChange DetectedAdded Revision: v3.4.2. The previous Revision: v3.4.1 notice and the government funding lapse notice were removed.SummaryDifference0.4%

- Check14 days agoChange DetectedAdded a site-wide notice about a lapse in government funding, warning that information may not be up to date and transactions may not be processed (with links to cc.nih.gov and opm.gov). Updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check21 days agoChange DetectedMinor UI and metadata updates include showing the glossary toggle, capitalization/style changes for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a revision tag updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 with no visible changes to core study details in the screenshot. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedLocations section updated to add Arizona, New York, Pennsylvania, and Utah sites and remove prior location blocks. The revision is labeled v3.3.3.SummaryDifference0.6%

- Check85 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2; this appears to be a metadata update without substantive changes to study details.SummaryDifference0.1%

Stay in the know with updates to Maintenance Therapy Trial: Odetiglucan & CD40 Agonist
Enter your email address, and we'll notify you when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.